Corrigendum to: Glioma-derived cancer stem cells are hypersensitive to proteasomal inhibition (EMBO reports, (2017), 18, 1, (150-168), 10.15252/embr.201642360)

Young Dong Yoo, Dae Hee Lee, Hyunjoo Cha-Molstad, Hyungsin Kim, Su Ran Mun, Changhoon Ji, Seong Hye Park, Ki Sa Sung, Seung A. Choi, Joonsung Hwang, Deric M. Park, Seung Ki Kim, Kyung Jae Park, Shin Hyuk Kang, Sang Cheul Oh, Aaron Ciechanover, Yong J. Lee, Bo Yeon Kim, Yong Tae Kwon

Research output: Contribution to journalComment/debatepeer-review

1 Citation (Scopus)

Abstract

Correction to: EMBO Reports (2017) 18: 150–168. DOI: 10.15252/embr.201642360 | Published online 19 December 2016 See also: previous corrigendum: EMBO Reports (2017) 18: 1671. DOI: 10.15252/embr.201744761 | Published online 1 September 2017 The authors recently noticed a labeling error in Figure 7F, which has been replaced by one with the correct labels. The labeling does not affect the conclusions of the experiment. The authors apologize for any inconvenience caused by this oversight. (Figure presented.).

Original languageEnglish
Article numbere46380
JournalEMBO Reports
Volume19
Issue number9
DOIs
Publication statusPublished - 2018 Sept

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Genetics

Fingerprint

Dive into the research topics of 'Corrigendum to: Glioma-derived cancer stem cells are hypersensitive to proteasomal inhibition (EMBO reports, (2017), 18, 1, (150-168), 10.15252/embr.201642360)'. Together they form a unique fingerprint.

Cite this